Exane Derivatives’s Monsanto Co MON Stock Holding History

Exane Derivatives’s Portfolio MON Stock Details MON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7	Closed	-$820	–	707
2018 Q1	$820	Hold	7	–	–	﹤0.01%	487
2017 Q4	$819	Hold	7	–	–	﹤0.01%	495
2017 Q3	$839	Hold	7	–	–	﹤0.01%	464
2017 Q2	$828	Hold	7	–	–	﹤0.01%	487
2017 Q1	$792	Hold	7	–	–	﹤0.01%	418
2016 Q4	$736	Hold	7	–	–	﹤0.01%	481
2016 Q3	$715	Hold	7	–	–	﹤0.01%	485
2016 Q2	$724	Hold	7	–	–	﹤0.01%	430
2016 Q1	$614	Sell	7 -131	-95%	-$11.8K	﹤0.01%	483
2015 Q4	$13.6K	Hold	138	–	–	﹤0.01%	313
2015 Q3	$11.8K	Hold	138	–	–	﹤0.01%	339
2015 Q2	$14.7K	Hold	138	–	–	﹤0.01%	350
2015 Q1	$15.5K	Hold	138	–	–	﹤0.01%	363
2014 Q4	$16.5K	Buy	+138	New	+$16K	﹤0.01%	396

Other funds holding MON

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

UFF

USA Financial Formulas Ada, Michigan $546M AUM 39.63% 1-Year Est. Return

CGT

Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

Exane Derivatives's MON Position: Q2 2018 in Review

Exane Derivatives sold out of Monsanto Co (MON) in Q2 2018, closing a stake of 7 shares — an estimated $820 sold.

Exane Derivatives first reported a position in MON in Q4 2014 and held it in 14 quarters. The position peaked at $16.5K in Q4 2014. 4 funds tracked by Wall St. Rank hold MON as of Q2 2018.

Exane Derivatives reported no remaining Monsanto Co position as of Q2 2018 after selling out during the quarter.
Exane Derivatives sold 7 Monsanto Co shares in Q2 2018, an estimated $820.
Exane Derivatives first reported a position in Monsanto Co in Q4 2014 and held it in 14 quarters.
Exane Derivatives's Monsanto Co position peaked at $16.5K in Q4 2014.
4 funds tracked by Wall St. Rank held Monsanto Co as of Q2 2018.

Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.